New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria, Switzerland, 2019-2020.
Options
BORIS DOI
Publisher DOI
PubMed ID
34545787
Description
Carbapenemase-producing Enterobacterales (CPE) bacteria are a critical global health concern; New Delhi metallo-β-lactamase (NDM) enzymes account for >25% of all CPE found in Switzerland. We characterized NDM-positive CPE submitted to the Swiss National Reference Center for Emerging Antibiotic Resistance during a 2-year period (January 2019-December 2020) phenotypically and by using whole-genome sequencing. Most isolates were either Klebsiella pneumoniae (59/141) or Escherichia coli (52/141), and >50% were obtained from screening swabs. Among the 108 sequenced isolates, NDM-1 was the most prevalent variant, occurring in 56 isolates, mostly K. pneumoniae (34/56); the next most prevalent was NDM-5, which occurred in 49 isolates, mostly E. coli (40/49). Fourteen isolates coproduced a second carbapenemase, predominantly an OXA-48-like enzyme, and almost one third of isolates produced a 16S rRNA methylase conferring panresistance to aminoglycosides. We identified successful plasmids and global lineages as major factors contributing to the increasing prevalence of NDMs in Switzerland.
Date of Publication
2021-10
Publication Type
Article
Keyword(s)
Enterobacterales Escherichia coli Klebsiella pneumoniae NDM New Delhi metallo-β-lactamase Switzerland antimicrobial resistance bacteria carbapenemase metallo-β-lactamase
Language(s)
en
Contributor(s)
Findlay, Jacqueline | |
Poirel, Laurent | |
Kessler, Julie | |
Nordmann, Patrice |
Additional Credits
Series
Emerging infectious diseases
Publisher
Centers for Disease Control and Prevention
ISSN
1080-6059
Access(Rights)
restricted